source Post navigation EASD 2023: A Deeper Dive Into Type 1 and Type 2 Diabetes – Medscape Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes – Business Wire